Navigation Links
CLARO Receives FDA-Clearance for Treatment of Acne
Date:10/29/2008

Handheld Device is First to Use IPL to Clear Acne Blemishes

COSTA MESA, Calif., Oct. 29 /PRNewswire/ -- CLRS Technology today announced the CLARO acne-clearing device received marketing clearance by the US Food & Drug Administration (FDA) for treatment of mild to moderate inflammatory acne. CLARO, the first hand-held device to use Intense Pulsed Light (IPL) for treatment of acne, will be available by prescription January 2009 from medical professionals, including dermatologists, family practitioners and pediatricians.

"CLARO represents a new option for women and men of all ages who suffer from inflammatory acne," said Richard Oberreiter, CEO and Founder, CLRS Technology. "Unlike other at-home devices on the market for acne treatment, CLARO uses clinically proven Intense Pulsed Light (IPL) technology, combining heat and light to clear acne fast."

CLARO is the company's first entry into the $225 million home device category, a dynamic part of the personal care market. According to Medical Insight Inc., the category is anticipated to grow to $1 billion in sales by 2012 as major corporations enter the field, including Palomar with Gillette, Syneron and Procter & Gamble and Light BioScience with L'Oreal.

"I am very impressed with the science and engineering behind CLARO and believe it will be an important tool for anyone who struggles to clear their chronic or stubborn acne," said Dr. Ronald Moy Former Co-Chief of the Department of Dermatology and Chief of Dermatologic Surgery, UCLA and the lead investigator for CLARO clinical studies. "As physicians, we prescribe a variety of topical and oral treatments to fight acne, but people still experience the frustrations of flare-ups that wreck havoc on their self-esteem and their social life. My patients will be thrilled to have the efficacy of professional IPL technology in treating acne safely at their own convenience, whenever they need to."

Using proprietary technology, CLARO delive
'/>"/>

SOURCE CLRS Technology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Permanent atrial fibrillation (AF) doubles the risk of stroke ... than 6 000 patients presented at ESC Congress today ... that a simple clinical assessment of the type of ... , Ischaemic stroke is the second cause of death ... and many more disabled patients each year. Annual direct ...
(Date:9/1/2014)... York (PRWEB) September 01, 2014 ... retrieve, organize and analyze biological and genetic data. ... the activity of developing software tools to generate ... to be confused with biological computation. While bioinformatics ... understanding of biology can its related concepts, biological ...
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web ... carefully, Top10BestSEOHosting.com is here to announce that JustHost, ... suppliers in 2014. , JustHost ( http://www.justhost.com/track/seohosts ) ... shared hosting plan. The company’s approach to hosting ... affordable, accessible and powerful enough for anyone to ...
(Date:9/1/2014)... San Diego, CA (PRWEB) September 01, 2014 ... website daily regarding all the latest information from the ... , The US FDA announced on August 28, ... are recalled (Class I) as the device ... FDA, the DePuy Synthes Craniomaxillofacial (CMF) Distraction System is ...
(Date:9/1/2014)... Mahwah, NJ (PRWEB) September 01, 2014 ... disorder (NEAD) is a psychological disorder that can have ... look very much like epileptic seizures however, they are ... rather by emotional triggers. It is estimated that ... than those affected by multiple sclerosis. , ...
Breaking Medicine News(10 mins):Health News:Permanent AF doubles risk of stroke compared to paroxysmal AF 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3Health News:The Northeast Regional Epilepsy Group (NEREG) Offers First Conference on Psychogenic Non-epileptic Seizures (PNES) on September 20, 2014 in New Jersey 2
... and people without health insurance especially vulnerable, study says ... an estimated 6,200 Americans are hospitalized for heat exposure. ... hospitalized died, according to the latest News and ... and Quality. , Severe heat exposure, which is ...
... a premier research company in San Jose, releases several research projects ... the product's current market scenario, factors influencing the market, growth drivers, ... development activities, and strategic corporate activity of major market participants. ... ...
... breathe clean air inside all workplaces,including restaurants and ... A poll released today,finds that voters from Boone, ... inside all workplaces, including restaurants and bars., ... percent), Northern Kentucky,voters support a law prohibiting smoking ...
... 9 The Congressional Budget,Office (CBO) estimates that ... (H.R. 6331) would decrease enrollment in Medicare,Advantage by ... years. Karen,Ignagni, President and CEO of America,s Health ... than two million seniors across the country stand ...
... N.J., July 9 Zeus Scientific, Inc. today,announced ... test for,methicillin-resistant Staphylococcus aureus (MRSA). The test is ... and nucleic acid,amplification of a target pathogen., ... new MRSA,test will enable healthcare professionals to identify ...
... at the University of Alabama at Birmingham (UAB) have ... Project. The project is a national consortium of cutting-edge ... survival for patients with a kind of malignant brain ... nine-member consortium, UAB will serve as the only research ...
Cached Medicine News:Health News:Heat Exposure a Dangerous Summer Threat 2Health News:Global Industry Analysts' Releases a Series of Medical Market Research Reports 2Health News:Global Industry Analysts' Releases a Series of Medical Market Research Reports 3Health News:Northern Kentucky Voters Support Smokefree Workplaces 2Health News:Northern Kentucky Voters Support Smokefree Workplaces 3Health News:Northern Kentucky Voters Support Smokefree Workplaces 4Health News:UAB joins elite brain cancer research group 2
(Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
(Date:8/29/2014)... PITTSBURGH , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage ... at the Australian and New Zealand Forensic Science ... Forensic Sciences in Adelaide, Australia ... discussion concerning the advancements that hyperspectral imaging can ... Jeffrey Beckstead , Director of Product Development ...
(Date:8/29/2014)... VANCOUVER, British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" ... 2014 fiscal year-end financial statements.  The Company recently changed ... to facilitate an application to list its common stock ... possible. DelMar,s financial statements as filed with ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... WARSAW, Ind., Oct. 3, 2011 Zimmer Holdings, Inc. (NYSE: ... quarter 2011 sales and earnings conference call will be broadcast ... 8:00 a.m. Eastern Time.  A news release detailing the quarterly ... the morning of the conference call. The ...
... In a presentation at the Congress of Neurological Surgeons ... reported that preliminary results of a pilot clinical trial ... safely and effectively control essential tremor (ET), a common ... Results from the study,s first 10 patients showed ...
Cached Medicine Technology:Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results 2Focused Ultrasound Shows Promise as a Noninvasive Deep Brain Treatment for Essential Tremor, a Condition That Affects Millions 2Focused Ultrasound Shows Promise as a Noninvasive Deep Brain Treatment for Essential Tremor, a Condition That Affects Millions 3Focused Ultrasound Shows Promise as a Noninvasive Deep Brain Treatment for Essential Tremor, a Condition That Affects Millions 4
Ideal for nucleus manipulation during phacoemulsification. Also used for manipulating and rotating IOLs within the anterior chamber. Round knurled handle...
Short, narrow paddle angled 45 degree inserts through the side port stab incision and is ideal for effective manipulation of the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique. Round knurled handle. Manufactured in titanium....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
Medicine Products: